Revolutionary Breakthrough in Pulmonary Fibrosis Treatment
Surrozen Inc. has recently published a study in “Respiratory Research” that showcases the potential of its Wnt mimetic antibody to effectively treat pulmonary fibrosis. Utilizing an acute bleomycin model, this preclinical research demonstrates the antibody’s ability to decrease inflammation and fibrosis while improving lung function. Understanding Pulmonary Fibrosis and Wnt Pathway’s Role Pulmonary fibrosis is […]